Bymetric
UK company intelligence
Spinout Active LTD

Company profile

Imanova Limited

UK company 07516277, incorporated on 3 February 2011.

Imanova Limited is a UK company with status Active founded in 2011.

Company number
07516277
Incorporated
3 Feb 2011
Companies House status
Active

Company identity

Browse spinouts
Founded / incorporated
3 February 2011

Company number 07516277

Verify at Companies House
Legal name
IMANOVA LIMITED
Company type
Private Limited Company
Region
Unknown
Registered address
BURLINGTON DANES BUILDING IMPERIAL COLLEGE LONDON, HAMMERSMITH HOSPITAL
DU CANE ROAD
LONDON
UNITED KINGDOM
W12 0NN
Insolvency history
No

Corporate ownership

Updated 07 Jul 2026 09:49

2 levels 1 ultimate controller
1
Company Active LTD
Imanova Limited
CRN 07516277
2
Direct controller Active LTD
Invicro UK Holdings, Limited
CRN 10829195
3
Ultimate controller Active LTD
Glo Healthcare UK Limited
CRN 14554125

Company events

Reference milestones and recent Companies House filing stream events.

5 events
17 Feb
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

30 Sep
2026

Accounts due

Accounts Due

Next accounts due date

03 Feb
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec
2024

Accounts filed

Accounts

Last accounts made up date

03 Feb
2011

Incorporated

Inception

Company registered at Companies House

Spinout profile

1 entry

Company description

Imanova is an innovative alliance between the UK's Medical Research Council and three world-class London Universities: Imperial College, Kings College and University College. Established in April 2011 as an independent company, Imanova and its partners bring together a breadth and depth of knowledge and expertise that will drive research and innovation in imaging sciences. Imanova will have a real impact on human health and the understanding of disease. Imanova now owns and manages the renowned Clinical Imaging Centre (CIC) located at Imperial College London's Hammersmith Hospital campus. This state of the art facility was developed by former owner GlaxoSmithKline, and has benefitted from £47million of investment in equipment and infrastructure since opening in 2007.

Project impact

Close collaboration on developing molecular imaging probes for neuroinflammation

Imanova Ltd
2011
http://www.imanova.co.uk/